Medtronic PLC Consolidated Balance Sheet $ millions April 26, 2019 Current assets Balance sheet assumptions Investments No change Accounts receivable, less allowance 20.4% of net sales Inventories, net 12.3% of net sales Other current assets 7% of net sales Goodwill No change Tax assets 5% of net sales Other assets 3.3% of net sales Accounts payable 6.4% of net sales Accrued compensation (current liability) 7.2% of net sales Accrued compensation and retirement benefits (noncurrent liability) No change Accrued income taxes (current liability) 1.9% of net sales Other accrued expenses 9.6% of net sales Accrued income taxes (noncurrent liability) 9.3% of net sales Deferred tax liabilities 4.2% of net sales Other liabilities 2.5% of net sales Ordinary shares No change Accumulated other comprehensive loss No change Net income attributable to noncontrolling interest $19 million Dividends in FY2020 $2,853 million CAPEX in FY2019 $1,134 \$million, forecast CAPEX at historic \% of net sales Depreciation expense in FY2020 $950 million Amortization expense in FY2020 $1,914 million Debt due in FY2020 $838 million Debt due in FY2021 $2,058 million Medtronic PLC Consolidated Balance Sheet \$ millions 2020 Current assets Cash and cash equivalents Investments Accounts receivable, net Inventories, net Other current assets Total current assets Property, plant, and equipment, net Goodwill Other intangible assets, net Tax assets Other assets Total assets \begin{tabular}{ll} & 0 \\ \hline & 0 \\ & 0 \\ & 0 \\ & 0 \\ & 0 \\ & 0 \\ \hline \hline & 0 \\ \hline \hline \end{tabular} Current liabilities Current debt obligations Accounts payable Accrued compensation Accrued income taxes Other accrued expenses Total current liabilities Long-term debt Accrued compensation and retirement benefits Accrued income taxes Deferred tax liabilities Other liabilities Total liabilities Shareholders' equity Ordinary shares Additional paid-in capital Retained earnings Accumulated other comprehensive loss Total shareholders' equity Noncontrolling interests Total equity Total liabilities and equity Medtronic PLC Consolidated Balance Sheet $ millions April 26, 2019 Current assets Balance sheet assumptions Investments No change Accounts receivable, less allowance 20.4% of net sales Inventories, net 12.3% of net sales Other current assets 7% of net sales Goodwill No change Tax assets 5% of net sales Other assets 3.3% of net sales Accounts payable 6.4% of net sales Accrued compensation (current liability) 7.2% of net sales Accrued compensation and retirement benefits (noncurrent liability) No change Accrued income taxes (current liability) 1.9% of net sales Other accrued expenses 9.6% of net sales Accrued income taxes (noncurrent liability) 9.3% of net sales Deferred tax liabilities 4.2% of net sales Other liabilities 2.5% of net sales Ordinary shares No change Accumulated other comprehensive loss No change Net income attributable to noncontrolling interest $19 million Dividends in FY2020 $2,853 million CAPEX in FY2019 $1,134 \$million, forecast CAPEX at historic \% of net sales Depreciation expense in FY2020 $950 million Amortization expense in FY2020 $1,914 million Debt due in FY2020 $838 million Debt due in FY2021 $2,058 million Medtronic PLC Consolidated Balance Sheet \$ millions 2020 Current assets Cash and cash equivalents Investments Accounts receivable, net Inventories, net Other current assets Total current assets Property, plant, and equipment, net Goodwill Other intangible assets, net Tax assets Other assets Total assets \begin{tabular}{ll} & 0 \\ \hline & 0 \\ & 0 \\ & 0 \\ & 0 \\ & 0 \\ & 0 \\ \hline \hline & 0 \\ \hline \hline \end{tabular} Current liabilities Current debt obligations Accounts payable Accrued compensation Accrued income taxes Other accrued expenses Total current liabilities Long-term debt Accrued compensation and retirement benefits Accrued income taxes Deferred tax liabilities Other liabilities Total liabilities Shareholders' equity Ordinary shares Additional paid-in capital Retained earnings Accumulated other comprehensive loss Total shareholders' equity Noncontrolling interests Total equity Total liabilities and equity